BMJ 2001;322:1019-1023 ( 28 April )

Papers

Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study

Eric J G Sijbrands, consultant, ^a Rudi G J Westendorp, professor, ^b Joep C Defesche, molecular biologist, ^a Paul H E M de Meier, consultant, ^c Augustinus H M Smelt, lecturer, ^c John J P Kastelein, lecturer. ^a

^a Department of Vascular Medicine and General Internal Medicine, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands, ^b Clinical Epidemiology, Leiden University Medical Centre, 2300RC Leiden, Netherlands, ^c Department of General Internal Medicine, Leiden University Medical Centre

Correspondence to: E J G Sijbrands nrexpert{at}euronet.nl

Objective: To estimate all cause mortality from untreated familial hypercholesterolaemia free from selection for coronary artery disease.
Design: Family tree mortality study.
Setting: Large pedigree in Netherlands traced back to a single pair of ancestors in the 19th century.
Subjects: All members of pedigree aged over 20 years with 0.5 probability of carrying a mutation for familial hypercholesterolaemia.
Main outcome measure: All cause mortality.
Results: A total of 70 deaths took place among 250 people analysed for 6950 person years. Mortality was not increased in carriers of the mutation during the 19th and early 20th century; it rose after 1915, reached its maximum between 1935 and 1964 (standardised mortality ratio 1.78, 95% confidence interval 1.13 to 2.76; P=0.003), and fell thereafter. Mortality differed significantly between two branches of the pedigree (relative risk 3.26, 95% confidence interval 1.74 to 6.11; P=0.001).
Conclusions: Risk of death varies significantly among patients with familial hypercholesterolaemia. This large variability over time and between branches of the pedigree points to a strong interaction with environmental factors. Future research is required to identify patients with familial hypercholesterolaemia who are at extreme risk and need early and vigorous preventive measures.

What is already known on this topic Familial hypercholesterolaemia is associated with excess mortality in families of patients who present with cardiovascular disease Population data are lacking What this study adds Many untreated patients with familial hypercholesterolaemia (about 40%) reach a normal life span Standardised mortality ratio was normal in the 19th century and rose to a peak in the 1930s to 1960s The variation in mortality suggests an interaction between genetic and environmental factors

---

© BMJ 2001
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Genes and environment determine survival in familial hypercholesterolaemia
BMJ 2001 322: 0. [Full Text]

This article has been cited by other articles:

• van der Net, J. B., Oosterveer, D. M., Versmissen, J., Defesche, J. C., Yazdanpanah, M., Aouizerat, B. E., Steyerberg, E. W., Malloy, M. J., Pullinger, C. R., Kastelein, J. J.P., Kane, J. P., Sijbrands, E. J.G. (2008). Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia. Eur Heart J 0: ehn303v1-7 [Abstract] [Full text]  
• van der Net, J. B., van Etten, J., Yazdanpanah, M., Dallinga-Thie, G. M., Kastelein, J. J.P., Defesche, J. C., Koopmans, R. P., Steyerberg, E. W., Sijbrands, E. J.G. (2008). Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia. Eur Heart J 29: 1370-1376 [Abstract] [Full text]  
• Maas, R., Schwedhelm, E., Kahl, L., Li, H., Benndorf, R., Luneburg, N., Forstermann, U., Boger, R. H. (2008). Simultaneous Assessment of Endothelial Function, Nitric Oxide Synthase Activity, Nitric Oxide-Mediated Signaling, and Oxidative Stress in Individuals with and without Hypercholesterolemia. Clin. Chem. 54: 292-300 [Abstract] [Full text]  
• Souverein, O. W., Defesche, J. C., Zwinderman, A. H., Kastelein, J. J.P., Tanck, M. W.T. (2007). Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia. Eur Heart J 28: 299-304 [Abstract] [Full text]  
• Koeijvoets, K. C. M. C., van Rossum, E. F. C., Dallinga-Thie, G. M., Steyerberg, E. W., Defesche, J. C., Kastelein, J. J. P., Lamberts, S. W. J., Sijbrands, E. J. G. (2006). A Functional Polymorphism in the Glucocorticoid Receptor Gene and Its Relation to Cardiovascular Disease Risk in Familial Hypercholesterolemia. J. Clin. Endocrinol. Metab. 91: 4131-4136 [Abstract] [Full text]  
• Damgaard, D., Faergeman, O. (2006). Genotypes or phenotypes in cardiovascular diagnosis?. Eur Heart J 27: 2150-2151 [Full text]  
• Rana, J. S., Jansen, A. C., Zwinderman, A. H., Nieuwdorp, M., van Aalst-Cohen, E. S., Jukema, J. W., Trip, M. D., Kastelein, J. J.P. (2006). Metabolic Syndrome and Risk of Coronary, Cerebral, and Peripheral Vascular Disease in a Large Dutch Population With Familial Hypercholesterolemia. Diabetes Care 29: 1125-1127 [Full text]  
• Mackenbach, J. P (2006). The origins of human disease: a short story on "where diseases come from". J. Epidemiol. Community Health 60: 81-86 [Abstract] [Full text]  
• Jansen, A. C.M., van Aalst-Cohen, E. S., Tanck, M. W.T., Cheng, S., Fontecha, M. R., Li, J., Defesche, J. C., Kastelein, J. J.P. (2005). Genetic Determinants of Cardiovascular Disease Risk in Familial Hypercholesterolemia. Arterioscler. Thromb. Vasc. Bio. 25: 1475-1481 [Abstract] [Full text]  
• Faergeman, O. (2005). The societal context of coronary artery disease. Eur Heart J Suppl 7: A5-A11 [Abstract] [Full text]  
• Lusis, A. J., Fogelman, A. M., Fonarow, G. C. (2004). Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways. Circulation 110: 1868-1873 [Full text]  
• Austin, M. A., Hutter, C. M., Zimmern, R. L., Humphries, S. E. (2004). Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review. Am J Epidemiol 160: 421-429 [Abstract] [Full text]  
• Humphries, S. E., Ridker, P. M., Talmud, P. J. (2004). Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?. Arterioscler. Thromb. Vasc. Bio. 24: 628-636 [Abstract] [Full text]  
• Ravnskov, U. (2003). High cholesterol may protect against infections and atherosclerosis. QJM 96: 927-934 [Full text]  
• Wiegman, A., Rodenburg, J., de Jongh, S., Defesche, J. C., Bakker, H. D., Kastelein, J. J.P., Sijbrands, E. J.G. (2003). Family History and Cardiovascular Risk in Familial Hypercholesterolemia: Data in More Than 1000 Children. Circulation 107: 1473-1478 [Abstract] [Full text]  
• Davey Smith, G., Ebrahim, S. (2003). 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 32: 1-22 [Abstract] [Full text]  
• Thorsson, B., Sigurdsson, G., Gudnason, V. (2003). Systematic Family Screening for Familial Hypercholesterolemia in Iceland. Arterioscler. Thromb. Vasc. Bio. 23: 335-338 [Abstract] [Full text]  
• Umans-Eckenhausen, M. A.W., Sijbrands, E. J.G., Kastelein, J. J.P., Defesche, J. C. (2002). Low-Density Lipoprotein Receptor Gene Mutations and Cardiovascular Risk in a Large Genetic Cascade Screening Population. Circulation 106: 3031-3036 [Abstract] [Full text]  
• Barth, J. D., Iglesias del Sol, A., Grobbee, D. E., Witteman, J. C.M., Bots, M. L. (2001). IMT for the Elderly?. Stroke 32: 2443-2445 [Full text]  
• (2001). Mortality Risk Varies in Patients with Familial Hypercholesterolemia. JWatch General 2001: 3-3 [Full text]  

Rapid Responses:

Read all Rapid Responses

The cause of mortality in patients with familial hypercholesterolaemia is actually complex

Sergio Stagnaro
bmj.com, 28 Apr 2001 [Full text]

Evidence that a high cholesterol does not cause atherosclerosis

Uffe Ravnskov
bmj.com, 30 Apr 2001 [Full text]

The rise and fall of heart disease

Jörgen Vesti-Nielsen
bmj.com, 30 Apr 2001 [Full text]

Familial Hypercholesterolaemia and Premature Coronary Heart Disease - The EARS Findings

Denis St J O'Reilly
bmj.com, 11 May 2001 [Full text]

Neuropathy from statins

Elias Ragi
bmj.com, 12 Nov 2001 [Full text]